<DOC>
	<DOCNO>NCT02895373</DOCNO>
	<brief_summary>Bleeding complication thromboembolic complication frequent extracorporeal membrane oxygenation ( ECMO ) . Retrospective data suggest platelet inhibition use prostaglandin , case PGE1 , may reduce thromboembolic complication without increase bleeding risk . This randomized , double-blind trial aim investigate effect PGE1 bleeding risk , thromboembolic complication function ECMO .</brief_summary>
	<brief_title>PGE1 Additive Anticoagulant ECMO-Therapy</brief_title>
	<detailed_description>Prostaglandins may inhibit platelet activation via P2Y1 ADP receptor . Platelets may contribute thromboembolic complication coagulation activation ECMO therapy . Retrospective data suggest treatment PGE1 may serve beneficial reduce amount heparin need inhibition coagulation activation , reduce thromboembolic risk without increase risk bleeding . Inhibition platelets via PGE1 ( Alprostadil ) may interest setting , , contrast platelet inhibitor , short half-life platelet remain susceptible activation potent agonist ( i.e . thrombin , ADP ) . Thus , although reduce contribution platelet coagulation activation , may affect safety participate subject . This randomized , double-blind , placebo control trial investigate whether treatment patient ECMO therapy prove beneficial .</detailed_description>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Acute Lung Injury</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<mesh_term>Alprostadil</mesh_term>
	<criteria>minimum age 18 year VenoVenous ECMO Minimum 24h plan ECMO therapy â€¢ Long term therapy antiplatelet drug include Acetyl Salicylic Acid know Heparin induce thrombocytopenia Bleeding diathesis = contraindication heparin ( e.g . GIbleeding , Intracerebral bleed ) Platelets &lt; 50 G/L Thromboplastin time &lt; 50 % Pregnancy Patient &lt; 18 year prothrombin time &lt; 50 % Drop criterion : Major bleeding ( Type 3 bleeding ; see `` primary objective '' ) Occurrence HIT ( 4 T Score : Number platelet , development time , manifestation thrombosis , reason thrombocytopenia [ 10 ] ) Plt &lt; 50 G/l</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>platelet inhibition</keyword>
	<keyword>alprostadil</keyword>
	<keyword>extracorporeal membrane oxygenation</keyword>
	<keyword>bleeding</keyword>
	<keyword>thromboembolic</keyword>
</DOC>